<?xml version='1.0' encoding='utf-8'?>
<document id="29788882"><sentence text="Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Taxus-based Drug Development." /><sentence text="Drug Metabolism and Pharmacokinetic (DMPK) studies of Taxus natural products, their semi-synthetic derivatives and analogs are indispensable in the optimization of lead compounds and clinical therapy" /><sentence text=" These studies can lead to development of new drug entities with improved Absorption, Distribution, Metabolism, Excretion and Toxicity (ADME/T) profiles" /><sentence text=" To date, there have been no comprehensive reviews of the DMPK features of Taxus derived medicinal compounds" /><sentence text=" Natural and semi-synthetic taxanes may cause and could be affected by Drug-drug Interaction (DDI)"><entity charOffset="28-35" id="DDI-PubMed.29788882.s5.e0" text="taxanes" /></sentence><sentence text=" Hence ADME/T studies of various taxane-containing formulations are important; to date these studies indicate that the role of cytochrome p450s and drug transporters is more prominent than phase II drug metabolizing enzymes"><entity charOffset="33-39" id="DDI-PubMed.29788882.s6.e0" text="taxane" /></sentence><sentence text=" Mechanisms of taxane DMPK mediated by nuclear receptors, microRNAs, and single nucleotide polymorphisms are being revealed"><entity charOffset="15-21" id="DDI-PubMed.29788882.s7.e0" text="taxane" /></sentence><sentence text="" /><sentence text="Herein we review the latest knowledge on these topics, as well as the gaps in knowledge of the DMPK issues of Taxus compounds" /><sentence text="" /><sentence text="DDIs significantly impact the PK/pharmacodynamics performance of taxanes and coadministered chemicals, which may inspire researchers to develop novel formula"><entity charOffset="65-72" id="DDI-PubMed.29788882.s11.e0" text="taxanes" /></sentence><sentence text=" While the ADME/T profiles of some taxanes are well defined, DMPK studies should be extended to more Taxus compounds, species, and Taxus - involved formulations, which would be streamlined by versatile omics platforms and computational analyses"><entity charOffset="35-42" id="DDI-PubMed.29788882.s12.e0" text="taxanes" /></sentence><sentence text=" Further biopharmaceutical investigations will be beneficial to the translation of bench findings to the clinical applications" /><sentence text="" /></document>